Risk factors for early progression of diffuse low-grade glioma in adults.

Q2 Medicine
Long Wang, Xuegang Li, Tunan Chen, Chao Zhang, Jiantao Shi, Hua Feng, Fei Li
{"title":"Risk factors for early progression of diffuse low-grade glioma in adults.","authors":"Long Wang,&nbsp;Xuegang Li,&nbsp;Tunan Chen,&nbsp;Chao Zhang,&nbsp;Jiantao Shi,&nbsp;Hua Feng,&nbsp;Fei Li","doi":"10.1186/s41016-022-00295-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To explore the risk factors for early progression of diffuse low-grade glioma in adults.</p><p><strong>Methods: </strong>A retrospective analysis of pathologic and clinical data of patients diagnosed with diffuse low-grade gliomas at Southwest Hospital between January 2010 and December 2014. The progression-free survival (PFS) less than 60 months was classified as the early progress group, and the PFS greater than 60 months was the control group for comparative analysis.</p><p><strong>Results: </strong>A total of 138 patients were included in this study, including 94 cases of astrocytoma and 44 cases of oligodendroglioma. There were 63 cases with 100% resection, 56 cases with 90-100% resection degree, and 19 cases with resection degree < 90%. The average follow-up time was 60 months, of which 80 patients progressed and 58 patients did not progress. The average progression-free survival was 61 months. The median progression-free survival was 60 months. There were 68 patients with PFS ≤ 60 months and 70 patients with PFS > 60 months. The two groups were compared for statistical analysis. In univariate analysis, there were significant differences in tumor subtype (p = 0.005), range (p = 0.011), volume (p = 0.005), location (p = 0.000), and extent of resection (p = 0.000). Multifactor analysis shows tumor location (HR = 4.549, 95% CI: 1.324-15.634, p = 0.016) and tumor subtype (HR = 3.347, 95% CI = 1.373-8.157, p = 0.008), and imcomplete resection is factors influencing early progression of low-grade glioma.</p><p><strong>Conclusions: </strong>Low-grade gliomas involving deep location such as basal ganglia, inner capsule, and corpus callosum are more likely to progress early, while incomplete resection is a risk factor in early progression of astrocytoma.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":" ","pages":"25"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526265/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Neurosurgical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s41016-022-00295-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To explore the risk factors for early progression of diffuse low-grade glioma in adults.

Methods: A retrospective analysis of pathologic and clinical data of patients diagnosed with diffuse low-grade gliomas at Southwest Hospital between January 2010 and December 2014. The progression-free survival (PFS) less than 60 months was classified as the early progress group, and the PFS greater than 60 months was the control group for comparative analysis.

Results: A total of 138 patients were included in this study, including 94 cases of astrocytoma and 44 cases of oligodendroglioma. There were 63 cases with 100% resection, 56 cases with 90-100% resection degree, and 19 cases with resection degree < 90%. The average follow-up time was 60 months, of which 80 patients progressed and 58 patients did not progress. The average progression-free survival was 61 months. The median progression-free survival was 60 months. There were 68 patients with PFS ≤ 60 months and 70 patients with PFS > 60 months. The two groups were compared for statistical analysis. In univariate analysis, there were significant differences in tumor subtype (p = 0.005), range (p = 0.011), volume (p = 0.005), location (p = 0.000), and extent of resection (p = 0.000). Multifactor analysis shows tumor location (HR = 4.549, 95% CI: 1.324-15.634, p = 0.016) and tumor subtype (HR = 3.347, 95% CI = 1.373-8.157, p = 0.008), and imcomplete resection is factors influencing early progression of low-grade glioma.

Conclusions: Low-grade gliomas involving deep location such as basal ganglia, inner capsule, and corpus callosum are more likely to progress early, while incomplete resection is a risk factor in early progression of astrocytoma.

Abstract Image

Abstract Image

Abstract Image

成人弥漫性低级别胶质瘤早期进展的危险因素。
背景:探讨成人弥漫性低级别胶质瘤早期进展的危险因素。方法:回顾性分析2010年1月至2014年12月西南医院弥漫性低级别胶质瘤患者的病理和临床资料。将小于60个月的无进展生存期(PFS)分为早期进展组,大于60个月的PFS为对照组进行比较分析。结果:本研究共纳入138例患者,其中星形细胞瘤94例,少突胶质细胞瘤44例。100%切除63例,90-100%切除56例,切除程度< 90% 19例。平均随访60个月,其中进展80例,无进展58例。平均无进展生存期为61个月。中位无进展生存期为60个月。PFS≤60个月68例,PFS > 60个月70例。对两组患者进行比较统计分析。在单因素分析中,肿瘤亚型(p = 0.005)、范围(p = 0.011)、体积(p = 0.005)、位置(p = 0.000)和切除程度(p = 0.000)存在显著差异。多因素分析显示,肿瘤部位(HR = 4.549, 95% CI: 1.324 ~ 15.634, p = 0.016)、肿瘤亚型(HR = 3.347, 95% CI = 1.373 ~ 8.157, p = 0.008)和切除不完全是影响低级别胶质瘤早期进展的因素。结论:累及基底节、内囊、胼胝体等深部的低级别胶质瘤更容易早期进展,而不完全切除是星形细胞瘤早期进展的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
224
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信